Velphoro (sucroferric oxyhydroxide) has been approved for the treatment of children with chronic kidney disease
EMA has recommended granting an extension of indication for Velphoro (sucroferric oxyhydroxide) to include control of serum phosphorus levels in children aged 2 years or older with chronic